Ligament Decompression Tool with Tissue Engaging Device

ABSTRACT

A method for treating stenosis in a spine comprises percutaneously accessing the epidural space in a stenotic region of interest, compressing the thecal sac in the region of interest to form a safety zonem, inserting a tissue removal tool into tissue in the working zone, using the tool to percutaneously reduce the stenosis; and utilizing imaging to visualize the position of the tool during at least a part of the reduction step. A tissue excision system for performing percutaneous surgery, comprises a cannula comprising a tissue-penetrating member having a distal end defining an aperture on one side thereof, an occluding member slidably received on or in the cannula and closing the aperture when the occluding member is adjacent the cannula distal end, means for engaging adjacent tissue via the aperture, and cutting means for resecting a section of the engaged tissue.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation of PCT application Serial No.PCT/US2005/027216 filed Jul. 29, 2005, and entitled “Spinal LigamentModification Devices”, which claims benefit of U.S. application Ser. No.60/592,099 filed Jul. 29, 2004, and entitled “Device for PercutaneousTreatment of Spinal Stenosis,” which is incorporated herein by referencein its entirety.

TECHNICAL FIELD OF THE INVENTION

The present invention relates to a minimally invasive method, device andsystem for treating spinal disorders using imaging guidance. Thisinvention also relates to devices used to reduce stenosis and increasethe cross-sectional area of the spinal canal and to devices used totreat excess fat within the spinal canal or epidural lipomatosis. Thisinvention also relates to methods, devices, therapies and medicationsused to treat disorders that involve the epidural space.

BACKGROUND OF THE INVENTION

The spine comprises a stack of vertebrae with an intervertebral discbetween adjacent vertebrae. As shown in FIG. 1, each vertebra 10includes a vertebral body 12 that supports a bony ring 14. The bony ring14 consists of laminae 16, spinous process 18, transverse processes 20,superior articular processes 22, and pedicles 24. Together withvertebral body 12, these vertebral components define the spinal canal.The laminae 16 are joined in the midline by the spinous process 18. Inthe cervical and thoracic region the dural sac 32 contains the spinalcord, which comprises nerves 34 surrounded by cerebrospinal fluid. Thefluid-filled sac is therefore compressible. The ligamentum flavum 26 isan elastic yellow ligament connecting the laminae of adjacent vertebrae.

In degenerative conditions of the spine, narrowing of the spinal canal(stenosis) can occur. Lumbar spinal stenosis is often defined as a duralsac cross-sectional area less than 100 mm2 or an anteroposterior (AP)dimension of the canal of less than 10-12 mm for an average male.

The source of most cases of lumbar spinal stenosis is thickening of theligamentum flavum. Spinal stenosis may also be caused by subluxation,facet joint hypertrophy, osteophyte formation, underdevelopment ofspinal canal, spondylosis deformans, degenerative intervertebral discs,degenerative spondylolisthesis, degenerative arthritis, ossification ofthe vertebral accessory ligaments and the like. A less common cause ofspinal stenosis, which usually affects patients with morbid obesity orpatients on oral corticosteroids, is excess fat in the epidural space.The excessive epidural fat compresses the dural sac, nerve roots andblood vessels contained therein and resulting in back and leg pain andweakness and numbness of the legs. Spinal stenosis may also affect thecervical and, less commonly, the thoracic spine.

Patients suffering from spinal stenosis are typically first treated withexercise therapy, analgesics and anti-inflammatory medications. Theseconservative treatment options frequently fail. If symptoms are severe,surgery is required to decompress the canal and nerve roots.

To correct stenosis in the lumbar region, an incision is made in theback and the muscles and supporting structures are stripped away fromthe spine, exposing the posterior aspect of the vertebral column. Thethickened ligamentum flavum is then exposed by removal of the bony arch(lamina) covering the back of the spinal canal (laminectomy). Thethickened ligament can then be excised with sharp dissection with ascalpel or punching instruments such as a Kerison punch that is used toremove small chips of tissue. The procedure is performed under generalanesthesia. Patients are usually admitted to the hospital forapproximately five to seven days depending on the age and overallcondition of the patient. Patients usually require between six weeks andthree months to recover from the procedure. Many patients need extendedtherapy at a rehabilitation facility to regain enough mobility to liveindependently.

Much of the pain and disability after an open laminectomy is due to thetearing and cutting of the back muscles, blood vessels and supportingligaments and nerves that occurs during the exposure of the spinalcolumn. Also, because these spine stabilizing back muscles and ligamentsare stripped and cut off, the spine these patients frequently developspinal instability post-operatively.

Minimally invasive techniques result in less post-operative pain andfaster recovery compared to traditional open surgery. Percutaneousinterventional spinal procedures can be performed with local anesthesia,thereby sparing the patient the risks and recovery time required withgeneral anesthesia. Another advantage is that there is less damage tothe paraspinal muscles and ligaments with minimally invasive techniquesreducing pain and preserving these important stabilizing structures.

Various techniques for minimally invasive treatment of the spine areknown. Microdiscectomy is performed by making a small incision in theskin and deep tissues to create a portal to the spine. A microscope isthen used to aid in the dissection of the adjacent structures prior todiscectomy. The recovery for this procedure is much shorter thantraditional open discectomies. Percutaneous discectomy devices withfluoroscopic guidance have been used successfully to treat disorders ofthe disc but not to treat spinal stenosis or the ligamentum flavumdirectly. Arthroscopy or direct visualization of the spinal structuresusing a catheter or optical system have also been proposed to treatdisorders of the spine including spinal stenosis however these devicesstill use miniaturized standard surgical instruments and directvisualization of the spine similar to open surgical procedures. Thesedevices and techniques are limited by the small size of the canal andthese operations are difficult to perform and master. Also theseprocedures are painful and often require general anesthesia. Thearthroscopy procedures are time consuming and the fiber optic systemsare expensive to purchase and maintain.

In addition, because the nerves of the spine pass through the core ofthe spine directly in front of the ligamentum flavum, any surgery,regardless of whether is open or percutaneous includes a risk of damageto those nerves.

Hence, it remains desirable to provide a simple method and device fortreating spinal stenosis and other spinal disorders without requiringopen surgery. It is further desired to provide a system whereby the riskof damage to the thecal sac containing the spinal nerves can be reduced.

SUMMARY OF THE INVENTION

The present invention provides a method, device and system for treatingspinal stenosis or other spinal disorders using image guidance incombination with percutaneous techniques. The present system is referredto as a minimally invasive ligament decompression (MILD) device. In someembodiments, the present invention provides a means for compressing thethecal sac within the epidural space so as to provide a safety zone inwhich further surgical procedures may be performed without risk ofdamaging nearby tissues or the thecal sac itself.

In further embodiments, the present method comprises the steps of a)percutaneously accessing the epidural space in a region of interest withimage guidance; b) at least partially compressing the thecal sac in theregion of interest by injecting a fluid into the epidural space to forma safety zone; c) percutaneously accessing a working zone in at leastone of the ligamentum flavum and overlying dorsal tissues with imageguidance, where the safety zone lies between the working zone and thecalsac; d) inserting a tissue removal tool into the working zone; e) usingthe tool remove tissue so as to reduce the stenosis; and f) utilizing atleast one imaging system to identify tissues for removal. By way ofexample, radiologic imaging may be used to safely guide the tool(s) totarget tissues and visualize the position of the tool during at leastpart of the process.

In preferred embodiments, the device provides an anchored pathway to theworking zone so that excised tissue can be shuttled out of the area forsuccessive extractions without time consuming repositioning of thetool(s). In other embodiments, the tool can be repositioned as often asis necessary to achieve the desired modifications. In still otherembodiments, the present invention includes percutaneous methods forplacing a retractable anchor in the ligamentum flavum and attaching itto the fascia or bone so as to retract the ligamentum flavum, thusexpanding the spinal canal. In still other embodiments, the inventionincludes a percutaneous mechanical suture system and method for placinga stitch in the ligament and then anchoring the stitch so as to retractthe ligamentum flavum. The laminotomy site can serve as a site for abone anchor and/or flange for a suture to anchor the ligament.

Particular embodiments of the invention include a method for treatingstenosis in a spine, the spine including a thecal sac and a canal and anepidural space therebetween, wherein the stenosis determines a region ofinterest in the spine. The method may comprise the steps of a)percutaneously accessing the epidural space in the region of interest,b) compressing the thecal sac in the region of interest by injecting afluid to form a safety zone and establish a working zone, with thesafety zone lying between the working zone and the thecal sac, c)inserting a tissue removal tool into tissue in the working zone, d)using the tool to percutaneously reduce the stenosis. It is preferred touse at least one imaging system to visualize the position of the toolduring at least a part of step d).

Step d) may include 1) engaging adjacent tissue in the working zone, 2)excising the engaged tissue, 3) removing the resulting tissue sectionfrom the working zone, and 4) repeating steps 1) through 3) until adesired amount of tissue has been removed. The removed tissue maycomprise a portion of the ligamentum flavum, fat, and/or bone.Alternatively, the step d) may include i) providing an anchor havingfirst and second tissue-engaging ends, ii) engaging the ligamentumflavum with the first tissue-engaging end, iii) using the engaged firstend to pull at least a portion of the ligamentum flavum into a desiredposition, and iv) using the second tissue-engaging end to anchor theanchor such that the ligamentum flavum is retained in a desiredposition. The anchor may be anchored to paraspinous tissue or to otherbone.

The invention also relates to an injectable fluid, which may include acontrast agent and may have a temperature-dependent viscosity such thatit is more viscous at 37° C. than at 30° C.

The tool of steps c) and d) may include an outer cannulated scalpel orneedle, a tissue-engaging means, and a cutting or resecting element andmay further include means for removing tissue from the tissue-engagingmeans. The tissue-engaging means may comprise a resilient hook.

Some embodiments of the invention may take the form of a kit forperforming a procedure on a spine, in which the kit includes aninsertion member for accessing the epidural space, and an expandabledevice adapted to be inserted into the epidural space by the insertionmember and expanded so as to compress a portion of the thecal sac andprovide a safety zone within the epidural space. The expandable devicemay comprise a volume of a contrast medium, such as a radio-opaquenon-ionic myelographic contrast medium, and/or may comprise a volume ofa medium that is injectable at ambient temperatures and more viscous atbody temperature. The contrast medium may include a bioactive agentand/or a steroid

The kit may further include a surgical device, which in turn maycomprise a hollow cannulated scalpel or outer needle having a sideaperture proximal its distal end, and an elongate body housed within theouter needle and comprising two radially extendable arms constructedsuch that radially extending the arms causes them to extend outwardthrough the side aperture and retracting said arms causes them to close.In other embodiments, the kit may comprise means for engaging theligamentum flavum and means for resecting a section of the ligamentumflavum and the means for resecting may in turn comprise a trocar, abarbed member coaxially received within the trocar, and a blade. Inother embodiments, the surgical device may comprise means for engaging afirst anatomical structure and means for affixing the first anatomicalstructure to a second anatomical structure. Alternatively, the surgicaldevice may comprise means for engaging the ligamentum flavum and softtissues in the Para spinal region of the patient so as to anchor theligamentum flavum, and/or means for engaging and retracting theligamentum flavum and means for anchoring the retracted ligamentumflavum

In still other embodiments, a percutaneous tool for treating a stenosedspine by removing tissue therefrom, comprises an cannulated scalpel, afirst tissue-engaging means housed within the cannulated scalpel, and acutting element configured to resect a sample of tissue that is engagedby the first tissue-engaging means. The cannulated scalpel may include aside aperture through which the first tissue-engaging means engages thetissue and the tool may further include a second tissue-engaging devicethat is adapted to remove the resected tissue sample from the firsttissue-engaging device. The second tissue-engaging device may comprise akeyhole slot.

In still other embodiments, a device for removing tissue from a stenosedspine may comprise a hollow outer needle having a side aperture proximalits distal end, an elongate body housed within the outer needle andcomprising two radially extendable arms constructed such that radiallyextending the arms causes them to extend outward through said sideaperture and retracting the arms causes them to close. Each arm mayinclude an opposing edge and at least one opposing edge may includeteeth or ridges or the opposing edges may comprise cutting blades.

In certain embodiments, the present percutaneous tissue excision systemmay include an inner needle having one or more barbs extending around120 degrees of its circumference. The barb(s) may be directed toward theproximal end of the needle. The tool may further include an occludingmember that closes a side aperture in the cannula may include a distalcutting edge adapted to cut tissue. The tool may further comprise anouter cutting member. The tissue-engaging components of the devicepreferably comprise a resilient metal that can withstand repeatedelastic deflections.

In yet further other embodiments, a method for preventing leakage ofcerebrospinal fluid from an opening in a thecal sac in a spine maycomprise accessing the epidural space in the vicinity of the opening andinserting a volume of fluid into the epidural space, where the fluidthickens as it attains body temperature such that the fluid blocks theopening in the thecal sac.

In further embodiments, a bone cutting device can be used to access theligamentum flavum and epidural space, to perform a laminotomy or toallow placement of a cannula. Using a cannula fixed within (extendingthrough) the lamina, a cutting device can be inserted into and removedfrom the ligamentum flavum and/or epidural space. Real-time use offluoroscopy or other imaging means during the subsequent MILD procedurecan be minimized with the appropriate placement of tools following useof the bone cutting device. The laminotomy creates a portal and gives asteady purchase for instruments and instrument exchange. In addition,either the laminotomy site or the neighboring tissue, including boneand/or other tissue, can be used as an anchoring site for sutures orother tissue-engaging means,

BRIEF DESCRIPTION OF THE DRAWINGS

For a more complete understanding of the invention, reference is made tothe accompanying drawings, wherein:

FIG. 1 is an illustration of a vertebra showing the spinal canal withthe thecal sac and a normal (un-stenosed) ligamentum flavum therein;

FIG. 2 is an illustration of a vertebra showing the spinal canal withthe thecal sac and a thickened ligamentum flavum therein;

FIG. 3 is an enlarged cross-section of the spine of FIG. 2, showing asafety zone created by compression of the thecal sac;

FIG. 4 is the enlarged cross-section of FIG. 3, showing a tissue removaltool positioned in the ligamentum flavum;

FIGS. 5-9 are a series of illustrations showing tissue excision by atissue-excision tool constructed in accordance with a first embodimentof the invention;

FIGS. 10-14 are a series of illustrations showing tissue excision by atissue-excision tool constructed in accordance with a second embodimentof the invention;

FIGS. 15 and 17 are sequential illustrations showing removal of tissuefrom a tissue-excision tool by a tissue-removal device constructed inaccordance with an embodiment of the invention;

FIGS. 16 and 18 are end views of the tissue-removal device of FIGS. 15and 17, respectively;

FIG. 19 shows an alternative embodiment of a grasping needle with acorkscrew shape;

FIG. 20 is a perspective view of a tissue-excision tool constructed inaccordance with a third embodiment of the invention;

FIGS. 21 and 22 are enlarged cross-sectional and perspective views,respectively, of the grasping device of FIG. 20 in its retractedposition;

FIGS. 23 and 24 are enlarged cross-sectional and perspective views,respectively, of the grasping device of FIG. 20 in its extendedposition;

FIG. 25 is a schematic illustration of one embodiment of a double-endedligament anchor being deployed in a ligamentum flavum;

FIG. 26 shows the device of FIG. 25 after full deployment;

FIG. 27 is a perspective view of an entire tool constructed inaccordance with preferred embodiments;

FIG. 28 is an enlarged cross-sectional view of the distal tip of thetool of FIG. 27 with the aperture partially opened;

FIG. 29 is a cross-sectional view of the handle end of the tool of FIG.27;

FIG. 30 is cross-section of a tissue-removal device constructed inaccordance with an alternative embodiment of the invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The epidural space is the space between the ligamentum flavum and thethecal sac. This space is filled with blood vessels and fat. The nervescontained within the thecal sac are normally surrounded by cerebrospinalfluid (CSF). When the ligamentum flavum hyperitrophies, the bloodvessels that supply the nerves of the cauda equina are compressed. Thisresults in ischemic pain termed spinal claudication. The nerve roots mayalso be compressed resulting in back and/or leg pain.

Referring again to FIG. 1 the posterior border of the normal epiduralspace 30 is formed by the normally thin ligamentum flavum 26 andposterior epidural fat (not shown). Ligamentum flavum 26 extends fromthe lamina above the interspinous space to the lamina below theinterspinous space. The dural sleeve (thecal sac) 32 contains nerveroots 34 surrounded by cerebrospinal fluid. The nerve roots 34 normallycomprise only a small proportion of the thecal sac volume.

In FIG. 2, spinal stenosis is present. Ligamentum flavum 26 is markedlythickened, compressing the posterior margin of dural sleeve 32. As shownin FIG. 2, the posterior margin of the dural sleeve 32 is apposed to theligamentum flavum and the epidural space is only a potential space.Because more than 90% of the volume of the thecal sac in the lumbarregion is filled by CSF, the thecal sac is highly compressible. Thus,even though stenosis may be causing compression of the thecal sac (andassociated pain or discomfort), in most instances it will be possible totemporarily compress the thecal sac further. Thus, according topreferred embodiments of the invention, thecal sac 32 is compressed in aregion of interest by applying pressure to the outside of the sac sothat at least a portion of the CSF is forced out of the region ofinterest.

Creation of Safety Zone

According to certain embodiments, thecal sac 32 is compressed byinjecting a standard radio-opaque non-ionic myelographic contrast mediumor other imagable or non-imagable medium into the epidural space in theregion of interest. This is preferably accomplished with a percutaneousinjection. The result is illustrated in FIG. 3. The presence of thefluid gently compresses and displaces the dural sleeve 32 in the regionof interest) creating a safety zone 40 between thecal sac 32 andligamentum flavum 26. Sufficient injectable fluid is preferably injectedto displace the CSF out of the region of interest and compress thethecal sac to at least a desired degree. The injected medium ispreferably substantially contained within the confines of the epiduralspace extending to the margins of the nerve root sleeves. The epiduralspace is substantially watertight and the fatty tissues andvascularization in the epidural space, combined with the viscousproperties of the preferred fluids, serve to substantially maintain theinjected medium in the desired region of interest. This novel method forprotecting the neural column may be referred to hereinafter as“contrast-guided dural protection.”

Once a safety zone 40 has been created, a tool 100, such as the tissueexcision devices and tissue retraction devices described below, can beinserted into the ligamentum flavum 26, as illustrated in FIG. 4. Whileit is preferred that the tip of the tool remain within the ligament asshown, the presence of safety zone 40 ensures that the thecal sac willnot be damaged even if the tool breaks through the anterior surface ofligament 26. For insertion of the tool, a fluoroscopic window of access(FWA) is defined by the inferior margin of the lamina (contra lateral tothe point of instrument entry in the soft tissues) and the dorsal marginof the contrast material that defines the epidural space. This FWA isroughly orthogonal to the long axis of the cutting instrument, whichparallels the inferior surface of the lamina as in FIG. 4. Thefluoroscopic plane of projection is preferably but not necessarilyoriented 20-45 degrees from normal (AP projection).

Because the present techniques are preferably performed percutaneously,certain aspects of the present invention can be facilitated by imaging.In this context, the spine can be imaged using any suitable technology,including but not limited to 2D, 3D fluoroscopy, CT, MRI, ultrasound orwith direct visualization with fiber optic or microsurgical techniques.Stereotactic or computerized image fusion techniques are also suitable.Fluoroscopy is currently particularly well-suited to the techniquesdisclosed herein. Fluoroscopic equipment is safe and easy to use,readily available in most medical facilities, relatively inexpensive. Ina typical procedure, using direct biplane fluoroscopic guidance andlocal anesthesia, the epidural space is accessed adjacent to thesurgical site as described above.

If the injected medium is radio-opaque, as are for example myelographiccontrast media, the margins of the expanded epidural space will bereadily visible using fluoroscopy or CT imaging. Thus, the safety zonecreated by the present contrast-guided dural compression techniques canreduce the risk of damage to the spinal cord during procedures to removeor displace portions of the ligamentum flavum and/or laminae in order totreat spinal stenosis.

Injectable Medium

If desired, the injected medium can be provided as a re-absorbablewater-soluble gel, so as to better localize the safety zone at the siteof surgery and reduce leakage of this protective layer from the spinalcanal. An injectable gel is a significant improvement on prior epiduralinjection techniques. The gel is preferably substantially more viscidthan conventional contrast media and the relatively viscid and/orviscous gel preferably tends to remain localized at the desired site oftreatment as it does not spread as much as standard liquid contrastmedia that are used in epidurography. The injected gel is preferablysufficiently viscous that it remains substantially within the localepidural space. This results in more uniform compression on the thecalsac and less leakage of contrast out of the canal. In addition,preferred embodiments of the gel are re-absorbed more slowly thanconventional contrast media, allowing for better visualization duringthe course of the surgical procedure.

In some embodiments, a contrast agent can be included in the gel itself,so that the entire gel mass is imagable. In other embodiments, an amountof contrast can be injected first, followed by the desired amount ofgel, or an amount of gel can be injected first, followed by the desiredamount of contrast. In this case, the contrast agent is captured on thesurface of the expanding gel mass, so that the periphery of the mass isimagable.

Any standard hydrophilic-lipophilic block copolymer (Pluronic) gel suchas are known in the art would be suitable and other gels may be used asthe injectable medium. The gel preferably has an inert base. In certainembodiments, the gel material is liquid at ambient temperatures and canbe injected through a small bore (such as a 27 gauge needle). The gelthen preferably becomes viscous when warmed to body temperature afterbeing injected. The viscosity of the gel can be adjusted through thespecifics of the preparation. The gel or other fluid is preferablysufficiently viscid or viscous at body temperature to compress andprotect the thecal sac in the manner described above and to remainsufficiently present in the region of interest for at least about 30minutes. Thus, in some embodiments, the injected gel attains a viscositythat is two, three, six or even ten times that of the fluids that aretypically used for epidurograms.

In certain embodiments, the injected medium undergoes a reversiblechange in viscosity when warmed to body temperature so that it can beinjected as a low-viscosity fluid, thicken upon injection into thepatient, and be returned to its low-viscosity state by cooling. In theseembodiments, the injected medium is injected as desired and thickensupon warming, but can be removed by contacting it with a heat removaldevice, such as an aspirator that has been provided with a cooled tip.As a result of localized cooling, the gel reverts to its initial nonviscous liquid state and can be easily suctioned up the cooled needle orcatheter.

An example of a suitable contrast medium having the desired propertiesis Omnipaque® 240 available from Nycomed, New York, which is acommercially available non-ionic iodinated myelographic contrast medium.Other suitable injectable media will be known to those skilled in theart. Because of the proximity to the spinal nerves, it is preferred notto use ionic media in the injectable medium. The preferred compositionsare reabsorbed relatively rapidly after the procedure. Thus any residualgel compression on the thecal sac after the MILD procedure resolvesrelatively quickly. For example, in preferred embodiments, the gel wouldhave sufficient viscosity to compress the thecal sac for thirty minutes,and sufficient degradability to be substantially reabsorbed withinapproximately two hours.

The injected contrast medium further may further include one or morebioactive agents. For example, medications such as those used inepidural steroid injection (erg. Depo medrol, Celestone Soluspan) may beadded to the epidural gel to speed healing and reduce inflammation,scarring and adhesions. The gel preferably releases the steroidmedication slowly and prolongs the anti-inflammatory effect, which canbe extremely advantageous. Local anesthetic agents may also be added tothe gel. This prolongs the duration of action of local anesthetic agentsin the epidural space to prolong pain relief during epidural anesthesia.In this embodiment the gel may be formulated to slow the reabsorption ofthe gel.

The present gels may also be used for epidural steroid injection andperineural blocks for management of acute and chronic spinal pain.Thrombin or other haemostatic agents can be added if desired, so as toreduce the risk of bleeding.

In some embodiments, the gel may also be used as a substitute for ablood patch if a CSF leak occurs. The gel may also be used as analternative method to treat lumbar puncture complications such aspost-lumbar puncture CSF leak or other causes of intracranialhypotension. Similarly, the gel may be used to patch postoperative CSFleaks or dural tears. If the dural sac were inadvertently torn or cut,then gel could immediately serve to seal the site and prevent leakage ofthe cerebral spinal fluid.

Percutaneous Tissue Excision

After safety zone 40 has been created, the margins of the epidural spaceare clearly demarcated by the injected medium and can be visualizedradiographically if an imagable medium has been used. As mentionedabove, percutaneous procedures can now safely be performed on theligamentum flavum and/or surrounding tissues without injuring the duralsac or nerves and the spinal canal can be decompressed using any ofseveral techniques. Suitable decompression techniques include removal oftissue from the ligamentum flavum, laminectomy, laminotomy, and ligamentretraction and anchoring.

In some embodiments, all or a portion of the ligamentum flavum and/orlamina are excised using a percutaneous tissue excision device or probe100, which may hereinafter be referred to as the MILD device. As shownschematically in FIG. 4, a device 100 may be placed parallel to theposterior and lateral margin of the safety zone 40 with its tip in theligamentum flavum 26.

Preferred embodiments of the present tissue excision devices andtechniques can take several forms. In the discussion below, the distalends of the tools are described in detail. The construction of theproximal ends of the tools, and the means by which the variouscomponents disclosed herein are assembled and actuated, will be knownand understood by those skilled in the art.

By way of example, in the embodiment shown in FIG. 4 and as illustratedin FIG. 5, device 100 may be a coaxial excision system 50 with asharpened or blunt tip that is placed obliquely into the thickenedligamentum flavum 26 posterior to safety zone 40 under fluoroscopicguidance. The needle is preferably placed parallel to the posteriormargin of the canal. Excision system 50 is preferably manufactured fromstainless steel, titanium or other suitable durable biocompatiblematerial. As shown in FIGS. 5-10, an outer needle or cannula 51 has anopening or aperture 52 on one side that is closed during insertion by aninner occluding member 54. Aperture 52 is readily visible under imagingguidance. Once needle 51 is positioned in the ligamentum flavum or othertissue removal site, inner occluding member 54 is removed or retractedso that it no longer closes aperture 52 (FIG. 6). Aperture 52 ispreferably oriented away from the epidural space so as to furtherprotect the underlying structures from injury during the surgicalprocedure. If it was not already present in the tool, a tissue-engagingmeans 56 is inserted through outer needle 51 to aperture 52 so that itcontacts adjacent tissue, e.g., the ligamentum flavum, via aperture 52.

Tissue-engaging means 56 may be a needle, hook, blade, tooth or thelike, and preferably has at least one flexible barb or hook 58 attachedto its shaft. The barb 58 or barbs may extend around approximately 120degrees of the circumference of the shaft. Barbs 58 are preferablydirected towards the proximal end of the tool. When needle 56 isretracted slightly, barbs 58 allow it to engage a segment of tissue.Depending on the configuration of barbs 58, the tissue sample engaged byneedle 56 may be generally cylindrical or approximately hemispherical.Once needle 56 has engaged the desired tissue, inner occluding means 54,which is preferably provided with a sharpened distal edge, is advancedso that it cuts the engaged tissue section or sample loose from thesurrounding tissue. Hence occluding means 54 also functions as a cuttingmeans in this embodiment. In alternative embodiments, such as FIGS.10-14 discussed below, a cylindrical outer cutting element 60 mayextended over outer needle 51 and used in place of occluding member 54to excise the tissue sample.

Referring still to FIGS. 5-9, once the tissue sample has been cut,tissue-engaging needle 56 can be pulled back through outer needle 51 sothat the segment of tissue can be retrieved and removed from the barbs(FIG. 8). The process or engaging and resecting tissue may be repeated(FIG. 9) until the canal is adequately decompressed.

Referring briefly to FIGS. 10-14, in other embodiments, atissue-engaging hook 64 can be used in place of needle 56 and an outercutting member 60 can be used in place of inner occluding member 54.Hook 64 may comprise a length of wire that has been bent through atleast about 270°, more preferably through 315°, and still morepreferably through about 405°. Alternatively or in addition, hook 64 maycomprise Nitinol™, or any other resilient metal that can withstandrepeated elastic deflections. In the embodiment illustrated, hook 64includes at least one barb 58 at its distal end. In some embodiments,hook 64 is pre-configured in a curvilinear shape and is retained withintool 100 by outer cutting member 60. When cutting member 60 isretracted, the curved shape of hook 64 urges its outer end to extendoutward through aperture 52. If desired, hook 64 can be advanced towardthe distal end of tool 100, causing it to extend farther into thesurrounding tissue. In some embodiments, hook 64 is provided with acamming surface 66. Camming surface 66 bears on the edge of opening 52as hook 64 is advance or retracted and thereby facilitates retractionand retention of hook 64 as it is retracted into the tool. In theseembodiments, hook 64 may not extend through aperture 52 until it hasbeen advanced sufficiently for camming surface 66 to clear the edge ofthe opening. Hook 64 may alternatively be used in conjunction with aninner occluding member 54 in the manner described above. As above, hook64 can be used to retrieve the engaged tissue from the distal end of thetool.

In still other embodiments, the tissue-engaging means may comprise ahook or tooth or the like that engages tissue via aperture 52 by beingrotated about the tool axis. In such embodiments (not shown) and by wayof example only, the tissue-engaging means could comprise a partialcylinder that is received in outer cannula 51 and has a serrated sideedge. Such a device can be rotated via a connection with the tool handleor other proximal device. As the serrated edge traverses aperture 52tissue protruding into the tool via the aperture is engaged by the edge,whereupon it can be resected and retrieved in the manner disclosedherein.

In preferred embodiments, the working tip of tool 100 remains within theligamentum flavum and does not penetrate the safety zone 40.Nonetheless, safety zone 40 is provided so that even an inadvertentpenetration of the tool into the epidural space will not result indamage to the thecal sac. Regardless of the means by which the tissue isengaged and cut, it is preferably retrieved from the distal end of thetool so that additional tissue segments can be excised without requiringthat the working tip of the tool be repositioned. A tissue-removaldevice such as that described below is preferably used to remove thetissue from the retrieval device between each excision.

Tissue Removal

Each piece of tissue may be removed from barbs 58 by pushingtissue-engaging means 56 through an opening that is large enough toallow passage of the flexible barbs and supporting needle but smallerthan the diameter of the excised tissue mass. This pushes the tissue uponto the shaft, where it can be removed with a slicing blade or the likeor by sliding the tissue over the proximal end of the needle.Alternatively, needle 56 can be removed and re-inserted into the toolfor external, manual tissue removal.

It is expected that in some embodiments, approximately 8-10 cores orsegments of tissue will be excised and pushed up the shaft towards thehub during the course of the procedure. Alternatively, a small blade canbe used to split the tissue segment and thereby ease removal of thesegment from the device. If desired, a blade for this purpose can beplaced on the shaft of needle 56 proximal to the barbs.

In an exemplary embodiment, shown in FIGS. 15-18, the tissue removaldevice may include a scraper 120 that includes a keyhole slot having awide end 122 and a narrow end 124. To remove a tissue sample from needle56 or hook 64, the tissue-engaging device with a mass of excised tissue110 thereon can be retracted (pulled toward the proximal end of thetool) through wide end 122 of the slot and then re-inserted (pushedtoward the distal end of the tool) through narrow end 124 of the slot.Narrow end 124 is large enough to allow passage of the barbed needle,but small enough to remove the tissue mass as the needle passes through.The removed tissue can exit the tool through an opening 113 in the toolbody. By shuttling the tissue-engaging device through scraper 120 inthis manner, each excised segment of tissue 110 can be removed from thedevice, readying the device for another excision.

In an alternative embodiment shown in FIG. 30, the tissue removal devicemay be constructed such that tissue is removed from the tissue-engagingdevice by retracting the tissue-engaging device through narrow end 124of the slot. As above, narrow end 124 is large enough to allow passageof the shaft of the tissue-engaging device, but small enough to removethe tissue mass as the needle passes through. If the tissue-engagingdevice is constructed of a tough material, the barbs or the like willcut through the tissue and/or deform and release the tissue. As above,the removed tissue can exit the tool through an opening 113 in the toolbody. By shuttling the tissue-engaging device through scraper 120 inthis manner, each excised segment of tissue 110 can be removed from thedevice, readying the device for another excision.

In another alternative embodiment (not shown) an alternative mechanismfor removing the tissue segment from needle 56 includes an adjustableaperture in a disc. After the tissue-bearing needle is pulled backthrough the aperture, the aperture is partially closed. Needle 56 andflexible hooks 58 then can pass through the partially closed aperturebut the larger cylinder of tissue cannot. Thus the tissue segment ispushed back onto the shaft. The tissue segment can either be pulled offthe proximal end of the shaft or cut off of it. A small blade may beplaced just proximal to the barbs to help cut the tissue segment off theshaft. The variable aperture can formed by any suitable construction,including a pair of metal plates with matching edges that each defineone half of a central opening. The two pieces may be held apart bysprings. The aperture may be closed by pushing the two edges together.In other embodiments, this process can be mechanically automated byusing a disc or plate with an opening that is adjustable by a variety ofknown techniques, including a slit screw assembly or flexible gaskets.

Other cutting and/or grasping devices can be used in place of the systemdescribed above. For example, embodiments of the grasping mechanisminclude but are not limited to: needles with flexible barbs, needleswith rigid barbs, corkscrew-shaped needles, and/or retaining wires. Thecorkscrew-shaped needle shown in FIG. 19 works by screwing into theligamentum flavum in the manner that a corkscrew is inserted in a cork.After the screw engages a segment of tissue, outer cutting element 60slides over the needle, cutting a segment of tissue in a manner similarto that of the previous embodiment. In some embodiments, the cuttingelement can be rotated as it cuts.

In other embodiments, shown in FIGS. 20-22, cannulated scalpel 5 housesa grasping device 70 that includes at least one pair of arcuate,closable arms 72. Closable arms 72 may be constructed in any suitablemanner. One technique for creating closable arms is to provide a slottedsleeve 74, as shown. Slotted member 74 preferably comprises an elongatebody 75 with at least one slot 76 that extends through its thickness butdoes not extend to either end of the body. Slot 76 is preferablyparallel to the longitudinal axis of the sleeve. On either side of slot76, a strip 77 is defined, with strips 77 being joined at each end ofsleeve 74. It is preferred that the width of each strip 77 be relativelysmall. In some embodiments, it may be desirable to construct slottedmember 74 from a portion of a hollow tube or from a rectangular piecethat has been curved around a longitudinal axis. The inner edge of eachstrip that lies along slot 76 forms an opposing edge 78. The width ofthe piece is the total of the width of strips 77 and slot 76.

Advancing one end of sleeve 74 toward the other end of sleeve 74 causeseach strip 77 to buckle or bend. If strips 77 are prevented frombuckling inward or if they are predisposed to bend in the desireddirection, they will bend outward, thereby forming arcuate arms 72,which extend through aperture 52 of cannulated scalpel 51, as shown inFIG. 21. As they move away from the axis of body 75, arms 72 move apartin a direction normal to the axis of body 75. Likewise, moving the endsof sleeve 74 apart causes arms 72 to straighten and to move together andinward toward the axis of the device, as shown in FIG. 22. As the armsstraighten, opposing edges 78 close and a segment of tissue can becapture between them. Tissue within the grasping device may then beresected or anchored via the other mechanisms described herein

Closable arms 72 may include on their opposing edges 78 ridges, teeth,or other means to facilitate grasping of the tissue. In otherembodiments, edges 78 may be sharpened, so as to excise a segment oftissue as they close. In these embodiments, closable arms 72 may also beused in conjunction with a hook, barbed needle, pincers or the like,which can in turn be used to retrieve the excised segment from thedevice.

Once arms 72 have closed on the tissue, if arms 72 have not cut thetissue themselves, the tissue can be excised using a blade such ascutting element 60 above. The excised tissue can be removed from theinside of needle 51 using a tissue-engaging hook 64 or other suitablemeans. The process of extending and closing arms 72, excising thetissue, and removing it from the device can be repeated until a desiredamount of tissue has been removed

If desired, this cycle can be repeated without repositioning the devicein the tissue. Alternatively, the tool can be rotated or repositioned asdesired between excisions. It is possible to rotate or reposition thetool during an excision, but it is expected that this will not generallybe preferred. Furthermore, it is expected that the steps of tissueexcision and removal can be accomplished without breaching the surfaceof the ligament, i.e. without any part of the device entering the safetyzone created by the injected fluid. Nonetheless, should the tool leavethe working zone, the safety zone will reduce the risk of injury to thethecal sac.

Ligament Retraction

In some embodiments, the spinal canal may also be enlarged by retractingthe ligamentum flavum, either with or without concurrent resection.Retraction is preferably but not necessarily performed after duralcompression has been used to provide a safety zone. In addition, thedural compression techniques described above have the effect of pressingthe ligamentum flavum back out of the spinal canal and thereby making iteasier to apply a restraining means thereto.

Thus, in preferred embodiments, after a safety zone is created byepidural injection of contrast medium or gel, a retraction device 90 asshown in FIG. 23 is used to retract and compress the thickened softtissues around the posterior aspect of the spinal canal, therebyincreasing the available space for the dural sac and nerves. In theembodiment shown, retraction device 90 is a double-headed anchor thatincludes at least one distal retractable tissue-engaging member 91 andat least one proximal tissue-engaging member 92, each of which aresupported on a body 94. Retraction device 90 is preferably constructedfrom an implantable, non-biodegradable material, such as titanium orstainless steel, but may alternatively be polymeric or any othersuitable material. In certain preferred embodiments, body 94 is somewhatflexible. In some instances, flexibility in body 94 may facilitate thedesired engagement of barbs 91, 92. Barbs 91, 92 may comprise hooks,arms, teeth, clamps, or any other device capable of selectively engagingadjacent tissue. Barbs 91, 92 may have any configuration that allowsthem to engage the ligamentum flavum and/or surrounding tissue.Similarly, barbs 91, 92 may be covered, sheathed, pivotable,retractable, or otherwise able to be extended from a first position inwhich they do not engage adjacent tissue to a second position in whichthey can engage adjacent tissue.

FIG. 23 shows schematically the distal and proximal retractable arms 91,92 of a preferred ligament anchor 90. The proximal end of the anchorpreferably includes a threaded connector 96 or other releasablemechanism that attaches to a support rod 100. Ligament anchor 90 may beattached to a support shaft 112 and sheathed in a guide housing 114. Thedistal and proximal barbs 91, 92 are prevented by guide housing 114 fromengaging surrounding tissue. Housing 102 is preferably a metal ordurable plastic guide housing.

The distal end of the device is preferably positioned in the ligamentumflavum under fluoroscopic guidance. If desired, an accessway through thelamina may be provided using an anchored cannula or the like. The deviceis held in position by support shaft 112. Distal barbs 91 are unsheathedand optionally expanded by pulling back guide housing 102, as shown inFIG. 23. Distal barbs 91 are secured in the ligamentum flavum by pullingback on the support shaft 112. With barbs 91 engaging the tissue, theligamentum flavum is retracted posteriorly by pulling back on supportshaft 112. While maintaining traction on the now-retracted ligament,proximal barbs 92 are uncovered and expanded by retracting guide housing114, as shown in FIG. 24. Barbs 92 are preferably positioned in the softtissues 116 in the para-spinal region so that the device is firmlyanchored behind the posterior elements of the spinal canal. Once theproximal end of the anchor is engaged, support shaft 112 may be detachedfrom body 94 as shown in FIG. 24. In this manner, the posterior margin95 of the ligamentum flavum can be held in a retracted position, therebyexpanding the canal. The procedure can then be repeated on adjacentportions of the ligamentum flavum until it is sufficiently retracted.

In an alternative embodiment, the proximal end of ligament anchor 90 maybe adapted to engage the lamina. This may be accomplished by having thearm posterior to the lamina or by using the laminotomy and suturing thedevice to the lamina there. A knotted or knotless system or a sutureplate can be used.

A second embodiment of the present method uses a plurality of retractiondevices 90. In this embodiment, the retraction device is insertedthrough one lamina in an oblique fashion, paralleling the oppositelamina. After the distal anchor is deployed, the retraction device ispulled back and across the ligamentum flavum, thereby decompressing theopposite lateral recess of the spinal canal. This is repeated on theopposite side. This same device can also be deployed with a directapproach to the lateral recess with a curved guide housing.

While retraction device 90 is describe above as a double-headed anchor,it will be understood that other devices can be used. For examplesutures, barbed sutures, staples or the like can be used to fasten theligament in a retracted position that reduces stenosis.

Using the percutaneous methods and devices described herein, significantreductions of stenosis can be achieved. For example, a dural saccross-sectional area less than 100 mm2 or an anteroposterior (AP)dimension of the canal of less than 10-12 mm in an average male istypically considered relative spinal stenosis. A dural saccross-sectional area less than 85 mm2 in an average male is consideredsevere spinal stenosis. The present devices and techniques areanticipated to cause an increase in canal area of 25 mm2 per anchor or50 mm2 total. With resection and/or retraction of the ligamentum flavum,the cross-sectional area of the dural sac can be increased by 10 mm2,and in some instances by as much as 20 mm2 or even 30 mm2. Likewise, thepresent invention can result in an increase of the anteroposteriordimension of the canal by 1 to 2 mm amid in some instances by as much as4 or 6 mm. The actual amount by which the cross-sectional area of thethecal sac and/or the anteroposterior dimension of the canal areincreased will depend on the size and age of the patient and the degreeof stenosis and can be adjusted by the degree of retraction of theligament.

MILD

The minimally invasive ligament decompression (MILD) devices andtechniques described herein allow spinal decompression to be performedpercutaneously, avoiding the pain and risk associated with open surgery.Through the provision of a safety zone, the present devices andtechniques offer reduced risk of spinal cord damage. In addition toimproving nerve function, it is expected that decompression of thespinal canal in the manner described herein will result in improvedblood flow to the neural elements by reducing the extrinsic pressure onthe spinal vasculature. For these reasons, it is believed that spinaldecompression performed according to the present invention will bepreferable to decompression operations performed using currently knowntechniques.

Dural Shield

In some embodiments (not shown), a mechanical device such as a balloonor mechanical shield can also be used to create a protective guard orbarrier between the borders of the epidural space and the adjacentstructures. In one embodiment a durable expandable device is attached tothe outside of the percutaneous laminectomy device, preferably on theside opposite the cutting aperture. The cutting device is inserted intothe ligamentum flavum with the expandable device deflated. With theaperture directed away from the spinal canal, the expandable device isgently expanded via mechanical means or inflated with air or anothersterile fluid, such as saline solution, via a lumen that may be withinor adjacent to the body of the device. This pushes the adjacent vitalstructures clear from the cutting aperture of the device andsimultaneously presses the cutting aperture into the ligament. As above,the grasping and cutting needles can then be deployed and operated asdesired. The balloon does not interfere with tissue excision because itis located on the side opposite the cutting aperture. The cutting needlemay be hemispherical (semi-tubular) in shape with either a straightcutting or a sawing/reciprocating blade or may be sized to be placedwithin the outer housing that separates the balloon from the cuttingaperture.

In another embodiment, a self-expanding metal mesh is positionedpercutaneously in the epidural space. First the epidural space isaccessed in the usual fashion. Then a guide catheter is placed in theepidural space at the site of the intended surgical procedure. The meshis preferably compressed within a guide catheter. When the outer coverof the guide catheter is retracted, the mesh expands in the epiduralspace, protecting and displacing the adjacent dural sheath. At theconclusion of the surgical procedure, the mesh is pulled back into theguide sheath and the assembly removed. The mesh is deformable andcompresses as it is pulled back into the guide catheter, in a mannersimilar to a self-expanding mesh stent. There are many commerciallyavailable self-expanding stents approved and in use in otherapplications. However, using a self expandable mesh as a device withinthe epidural space to protect and displace the thecal sac is novel

While preferred embodiments of this invention have been shown anddescribed, modifications thereof can be made by one skilled in the artwithout departing from the scope or teaching of this invention. Forexample, the means by which the safety zone is formed may be varied, theshape and configuration of the tissue excision devices may be varied,and the steps used in carrying out the technique may be modified.Accordingly, the invention is not limited to the embodiments describedherein, but is only limited by the claims that follow, the scope ofwhich shall include all equivalents of the subject matter of the claims.Likewise, the sequential recitation of steps in a claim, unlessexplicitly so stated, is not intended to require that the steps beperformed in any particular order or that a particular step be completedbefore commencement of another, step.

1. A tissue excision system for percutaneous surgery, comprising: acannula comprising a tissue-penetrating member having a distal enddefining an aperture on one side thereof; an occluding member slidablyreceived on or in said cannula and closing said aperture when saidoccluding member is adjacent said cannula distal end; means for engagingadjacent tissue via said aperture; and cutting means for resecting asection of said engaged tissue.
 2. The percutaneous tissue excisionsystem of claim 1 wherein said engaging means comprises atissue-engaging needle having a shaft and distal and proximal ends, andwherein said tissue-engaging needle is adapted for insertion throughsaid cannula, said tissue-engaging needle comprising at least one barbextending outwardly from said shaft.
 3. The percutaneous tissue excisionsystem of claim 1 wherein said engaging means is reciprocably receivedin said cannula.
 4. The percutaneous tissue excision system of claim 1wherein said engaging means is rotatably received in said cannula. 5.The percutaneous tissue excision system of claim 1 wherein said engagingmeans is constructed such that it has a normal configuration that isretained by said occluding member when said occluding member is adjacentsaid cannula distal end and extends through said aperture when saidoccluding member is removed from said aperture.
 6. The percutaneoustissue excision system of claim 1, further including means forretrieving said resected tissue from said distal tool end and atissue-removal system for removing tissue from said retrieving means. 7.The percutaneous tissue excision system of claim 6 wherein saidtissue-removal system comprises a keyhole slot.
 8. The percutaneoustissue excision system of claim 1 wherein the first tissue-engagingdevice comprises a hook.
 9. The percutaneous tissue excision system ofclaim 17 wherein said hook comprises a length of wire that has been bentthrough at least about 270°.
 10. The percutaneous tissue excision systemof claim 1 wherein said engaging means comprises an elongate body housedwithin said cannula and comprising two radially extendable armsconstructed such that radially extending said arms causes them to openand extend outwardly through said side aperture and retracting said armscauses them to close.
 11. The device according to claim 10 wherein saidarms each include an opposing edge and at least one opposing edgeincludes teeth or ridges.
 12. The device according to claim 10 whereinsaid opposing edges comprise cutting blades.
 13. The device according toclaim 10, further including a outer cutting element slidably mounted onsaid cannula.
 14. The device according to claim 10, further including aretractable tissue-engaging device received within said elongate body.15. The device according to claim 14 wherein said tissue-engaging devicecan be extended to the distal end of the cannula to engage a tissuesample, retracted for removal of the tissue sample, and re-extended intothe cannula.
 16. The device according to claim 14, further includingmeans for removing tissue from the tissue-engaging device.
 17. A methodfor treating stenosis in a spine, the spine including a thecal sac and acanal and an epidural space therebetween, the stenosis determining aregion of interest in the spine, comprising the steps of: a)percutaneously accessing the epidural space in the region of interest;b) compressing the thecal sac in the region of interest by injecting afluid to form a safety zone and establish a working zone, the safetyzone lying between the working zone and the thecal sac; c) inserting atissue removal tool into tissue in the working zone; d) using the toolto percutaneously reduce the stenosis; and e) utilizing imaging tovisualize the position of the tool during at least a part of step d).18. The method of claim 17 wherein the tool comprises: a cannulacomprising a tissue-penetrating member having a distal end defining anaperture on one side thereof; an occluding member slidably received onor in said cannula and closing said aperture when said occluding memberis adjacent said cannula distal end; means for engaging adjacent tissuevia said aperture; and cutting means for resecting a section of saidengaged tissue.
 19. The method of claim 18 wherein the tool furtherincludes means for retrieving said resected tissue from said distal toolend and a tissue-removal system for removing tissue from said retrievingmeans.
 20. The method of claim 17 wherein step d) comprises d1) engaginga tissue sample in the working zone; d2) excising the tissue sample; d3)removing the tissue sample from the working zone; and d4) repeatingsteps d1) through d3) until a desired amount of tissue has been removed.21. The method of claim 20 wherein the tissue sample comprises tissueselected from the group consisting of the ligamentum flavum, fat, andbone.
 22. The method of claim 20 wherein step d) is carried out withoutrepositioning the device in the tissue.
 23. The method of claim 20wherein step d) comprises di) providing an anchor having first andsecond tissue-engaging ends; dii) engaging the ligamentum flavum withsaid first tissue-engaging end; diii) using said engaged first end topull at least a portion of the ligamentum flavum into a desiredposition; and div) using said second tissue-engaging end to anchor saidanchor such that said ligamentum flavum is retained in a desiredposition.
 24. The method of claim 23 wherein step div) comprisesanchoring said anchor to paraspinous tissue.
 25. The method of claim 23wherein step div) comprises anchoring said anchor to bone.
 26. Themethod of claim 23 wherein the injected fluid includes a contrastmedium.
 27. The method of claim 23 wherein the injected fluid has atemperature-dependent viscosity and is more viscous at 37° C. than at30° C.
 28. A kit for performing a procedure on a spines the spineincluding an epidural space containing a thecal sac, the kit comprising:an insertion member for accessing the epidural space; an expandabledevice adapted to be inserted into the epidural space by the insertionmember and expanded so as to compress a portion of the thecal sac andprovide a safety zone within the epidural space.
 29. The kit accordingto claim 28 wherein said expandable device comprises a volume of acontrast medium.
 30. The kit according to claim 29 wherein the contrastmedium comprises a radio-opaque non-ionic myelographic contrast medium.31. The kit according to claim 28 wherein said expandable devicecomprises a volume of a medium that is injectable at ambienttemperatures and more viscous at body temperature.
 32. The methodaccording to claim 28 wherein the contrast medium includes a bioactiveagent.
 33. The method according to claim 28 wherein the contrast mediumincludes a steroid.
 34. The kit according to claim 28, further includinga surgical device.
 35. The kit according to claim 34 wherein saidsurgical device comprises: a cannulated scalpel having a side apertureproximal its distal end; an elongate body housed within said cannulatedscalpel and comprising two radially extendable arms constructed suchthat radially extending said arms causes them to extend outward throughsaid side aperture and retracting said arms causes them to close. 36.The kit according to claim 34 wherein said surgical device comprises atool including means for engaging the ligamentum flavum and means forresecting a section of the ligamentum flavum.
 37. The kit according toclaim 34 wherein said surgical device comprises. a cannula a sideaperture proximal its distal end; a barbed member coaxially receivedwithin said cannula; and a cutting member received on said cannula. 38.The kit according to claim 34 wherein said surgical device includesmeans for engaging a first anatomical structure and means for affixingsaid first anatomical structure to a second anatomical structure. 39.The kit according to claim 34 wherein said surgical device includesmeans for engaging and retracting the ligamentum flavum and means foranchoring the retracted ligamentum flavum.